immunosuppression
Advertisement
Immunomodulator cotherapy has been shown to improve the efficacy of pegloticase by reducing its immunogenicity. Results ...
The mortality risk from COVID-19 is increased in kidney transplant recipients. A. O. Gérard and colleagues conducted a ...
Following solid-organ transplantation, the primary aim of care is preventing allosensitization. Despite potent ...
In recent years, long-term graft survival after kidney transplantation has improved, due, in part, to advances in ...
Low-intensity immunosuppressive therapy for chronic graft-versus-host disease (cGVHD) is effective, according to a study ...
A retrospective study found that patients with preexisting autoimmune diseases (PADs) may experience exacerbations ...
Survey data results suggest that kidney transplant recipients who are considered tolerant (off immunosuppression) report ...
In a recent clinical trial, researchers led by Gaiqin Pei, MM, sought to examine the effect of immunosuppression ...
Recipients of solid organ transplants commonly experience hyperkalemia, limiting use of pharmacotherapy in those ...
Medicare coverage for kidney transplant recipients ceases 36 months following transplantation. The 36-month removal ...
In a case study published in Blood Advances, researchers detail the account of a patient with multiple myeloma (MM) and ...
A study analyzed the prevalence of opportunistic infections in patients with juvenile idiopathic arthritis (JIA).
...
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.